Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

Hyderabad: Amgen, a biotechnology major from the US, is making an investment of Rs 1,600 crore in Hyderabad by 2025-end. As ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...

The employees at the new Amgen campus will reach to 600 by the end of this year and is expected to provide employment to over ...

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...

Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...

US biopharma major Amgen is investing USD 200 million this year in its new facility here and plans to make significant investments in the coming years, the company’s CEO Robert Bradway said on Monday.

American multinational biopharmaceutical company, Amgen will be investing USD 200 million (about Rs 1600 crore) in its new ...

Amgen, a leading American biopharmaceutical company, is set to invest $200 million in a new Technology and Innovation Centre.

Amgen inaugurates its new Technology and Innovation center in Hyderabad, investing USD 200 million this year. The center will create job opportunities in the biopharma sector.